EQS-News: Eckert & Ziegler: Outstanding Training Quality Once Again Awarded

Berlin, July 15, 2025. Eckert & Ziegler SE (ISIN DE0005659700) has been recognized by the Berlin Chamber of Industry and Commerce (IHK) for the exceptional quality of its training program for the fourth time in a row. The Berlin-based healthcare company already held the award for “Excellent Training Quality” from 2019 to 2020, from 2021 to 2023 and from 2023 to 2025. In addition to successfully fulfilling all mandatory criteria, Eckert & Ziegler also scored highly in the voluntary and excellence criteria thanks to its long-standing commitment to training.

“Our trainees have the opportunity to gain valuable practical experience in a future-oriented growth area and take on varied tasks that allow them to be creative, contribute their own ideas, and take on responsibility," explains Dr. Harald Hasselmann, CEO of Eckert & Ziegler SE. “With a retention rate of around 70%, we also offer young talent real career prospects after completing their training. After all, well-trained specialists are essential for the success of a company.”

The Chamber of Industry and Commerce evaluated the training program at Eckert & Ziegler based on more than 30 including mandatory and excellence criteria. Among others, the framework conditions for trainees and training supervisors as well as the implementation and supervision of the individual training programs were evaluated. Particularly convincing were the individual work schedules of the trainees, which were adapted to the training plans, as well as the measures for team building and maintaining the trainee team across the various training professions. Eckert & Ziegler also scored highly for involving trainees in independent projects at an early stage, thereby enhancing their social skills.

Eckert & Ziegler trains industrial clerks, chemical laboratory assistants, IT specialists for system integration, and mechatronics engineers. There are still places available for the training program starting on September 1, 2026. We look forward to receiving your applications.

About Eckert & Ziegler.
Eckert & Ziegler SE with more than 1.000 employees, is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDax index of Deutsche Börse.
Contributing to saving lives.

Contact:
Eckert & Ziegler SE
Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138
karolin.riehle@ezag.de
www.ezag.com